{{Rsnum
|rsid=3135718
|Gene=FGFR2
|Chromosome=10
|position=123353869
|Orientation=minus
|GMAF=0.4555
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{PMID Auto
|PMID=19536173
|Title=Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia
|OA=1
}}

{{PharmGKB
|RSID=rs3135718
|Name_s=
|Gene_s=FGFR2
|Feature=
|Evidence=PubMed ID:19536173
|Annotation=The G allele of this variant was significantly associated with breast cancer risk in a study of the Russian population of 766 case and 665 control women from Siberia, Russian Federation. OR=1.43 (1.27-1.58), P=6 x 10(-6). This variant is in strong LD (r(2)=0.95) with rs2981582 in their sample.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA164918235
}}{{PMID Auto
|PMID=19223389
|Title=FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
|OA=1
}}{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3135718
|overall_frequency_n=64
|overall_frequency_d=128
|overall_frequency=0.5
|n_genomes=39
|n_genomes_annotated=0
|n_haplomes=54
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}